Erik Gustafson
Oncology Account Specialist
Jakafi (ruxolitinib)
Pemazyre (pemigatinib)
egustafson@incyte.com
(612) 875-2575

Ashley Palmer
Oncology Therapeutic Specialist
Jakafi (ruxolitinib)
Pemazyre (pemigatinib)
epalmer@incyte.com 
(605) 860-9310

Jenny Dahlke
Oncology Therapeutic Specialist
Jakafi (ruxolitinib)
Pemazyre (pemigatinib)
jdahlke@incyte.com
(612) 357-0952

Dain Moe
Oncology Therapeutic Specialist
Monjuvi (tafacitamab)
dmoe@incyte.com
(612) 940-1544

Virtual Exhibit Hall Home

Incyte is a global biopharmaceutical company that is focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of novel medicines.

Since 2002 Incyte has remained committed to the relentless pursuit of science that can improve the lives of patients, make a difference in healthcare and build sustainable value for our stakeholders.

Incyte’s unique expertise in medicinal chemistry and biology have enabled us to create a diversified pipeline of clinical candidates, the majority of which were discovered by Incyte scientists. We are advancing a growing portfolio of medicines across two franchises: Oncology and Inflammation & Autoimmunity.

Headquartered in Wilmington, Delaware, Incyte has operations in the U.S., Canada, Europe and Japan.

For more information, visit Incyte.com and follow @Incyte.

To contact US Medical Information, please call or email at 1-855-4MED-INFO (855-463-3463) or medinfo@incyte.com.

Jakafi Information

Monjuvi Information